Stability of Plasmonic Mg-MgO Core–Shell Nanoparticles in Gas-Phase Oxidative Environments by Vladimir Lomonosov (15213945)

“…Furthermore, we show that the reactivity of Mg-MgO nanoplates with water vapor (3.5 vol % in N₂) decreases with temperature, with no oxidation of the Mg core detected from 200 to 400 °C. …”

Anti-TNF antibody hampered the rIFNγ-induced augment of U-87 MG cells infection by <i>T</i>. <i>cruzi</i>. by Glaucia Vilar-Pereira (686134)

Data_Sheet_1_Secondhand Smoke Decreased Excitability and Altered Action Potential Characteristics of Cardiac Vagal Neurons in Mice.PDF by Junqing Sun (4688998)

“…</p><p>Methods: Adult male mice were exposed to four weeks of filtered air or SHS (3 mg/m³) 6 h/day, 5 day/week. Using patch-clamp recordings on identified CVNs in brainstem slices, we determined neuronal excitability and AP characteristics with depolarizing step- and ramp-current injections.…”

Functional linear modeling (FLM) of activity data following intramuscular administration of either 0.1 mL saline, 0.4 mg/kg meloxicam, 2.2 mg/kg flunixin or 3.0 mg/kg ketoprofen in... by Emma Nixon (11772946)

Subjects:

Total plasma cortisol concentration over time following intramuscular administration of either 0.1 mL saline, 0.4 mg/kg meloxicam, 2.2 mg/kg flunixin or 3.0 mg/kg ketoprofen in 6-d... by Emma Nixon (11772946)

Subjects:

Chun Fai Martin Cheng: How can we decrease metabolism in the New Zealand green-lipped mussels, Perna canaliculus, for better transport? by Cheng Martin (11717816)

ROC curve and P-R curve (attack traffic proportion = 10%). by Longyan Ran (18452261)

Temporal profiles of the key BO-NN features. by Julia Berezutskaya (9080269)

“…<p><b>(a)</b> Autocorrelation profiles of 53 key BO-NN features. Per feature, a black line shows the time point where the autocorrelation drops below .5. …”

Experimental outline. by Melissa A. MacIver (12850566)

Subjects:

Design, Synthesis, and Biological Evaluation of [1,2,5]Oxadiazolo[3,4‑<i>b</i>]pyridin-7-ol as Mitochondrial Uncouplers for the Treatment of Obesity and Metabolic Dysfunction-Assoc... by Mary A. Foutz (20361830)

“…Pharmacokinetic studies indicated a half-life of 2 h, <i>C</i>_max of 35 μM, and no observed adverse effects at 1,000 mg kg^–1 dose in mice. In a Gubra-Amylin (GAN) mouse model of MASH, <b>SHO1122147</b> was efficacious in decreasing body weight and liver triglyceride levels at 200 mg kg^–1 day^–1 without changes in body temperature. …”

ngLVA degradation kinetics. by Nicole A. Grieshaber (11175417)

cMSC/Collagen Type I gel fabrication. by Melissa A. MacIver (12850566)

Subjects:

Characterization of passage 1 (P1) bone marrow-derived canine mesenchymal stromal cells (cMSCs). by Melissa A. MacIver (12850566)

Subjects:

Pathway associated with decreased inflammation. by Monica N. Mweetwa (17054522)

DataSheet_1_UFR2709, a Nicotinic Acetylcholine Receptor Antagonist, Decreases Ethanol Intake in Alcohol-Preferring Rats.docx by Gabriel Quiroz (8068676)

Image_2_Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.PDF by Nicole C. McCoy (12459036)

“…The implementation group showed significantly reduced median intraoperative (20.0 mg vs. 0.0 mg; p < 0.001) and total opioid consumption (20.5 mg vs. 0.0 mg; p < 0.001). …”

Image_1_Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.PDF by Nicole C. McCoy (12459036)

“…The implementation group showed significantly reduced median intraoperative (20.0 mg vs. 0.0 mg; p < 0.001) and total opioid consumption (20.5 mg vs. 0.0 mg; p < 0.001). …”

Image_3_Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.PDF by Nicole C. McCoy (12459036)

“…The implementation group showed significantly reduced median intraoperative (20.0 mg vs. 0.0 mg; p < 0.001) and total opioid consumption (20.5 mg vs. 0.0 mg; p < 0.001). …”

Fig 5 - by Rajnish Prakash Singh (2847608)

Quantitation of free glycation compounds in saliva by Friederike Manig (7400603)

“…Within two days, salivary Pyr was lowered from median 1.7 ng/ml to a minimum level below the limit of detection, and MG-H1 decreased from 3.6 to 1.7 ng/ml in in a time-dependent manner after two days. …”